SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:liu-109245"
 

Sökning: onr:"swepub:oai:DiVA.org:liu-109245" > Comparison of high-...

Comparison of high-dose-rate Ir-192 source strength measurements using equipment with traceability to different standards

Carlsson Tedgren, Åsa (författare)
Östergötlands Läns Landsting,Linköpings universitet,Centrum för medicinsk bildvetenskap och visualisering, CMIV,Avdelningen för radiologiska vetenskaper,Hälsouniversitetet,Radiofysikavdelningen US,Swedish Radiation Safety Authority, Stockholm, Sweden
Bjerke, Hans (författare)
Norwegian Radiation Protection Authority, Österås, Norway
Grindborg, Jan-Erik (författare)
Swedish Radiation Safety Authority, Stockholm, Sweden
visa fler...
Hetland, Per-Otto (författare)
Norwegian Radiation Protection Authority, Österås, Norway
Kosunen, Antti (författare)
STUK-Radiation and Nuclear Safety Authority, Helsinki, Finland
Paulsen Hellebust, Taran (författare)
Oslo University Hospital, Norway; University of Oslo, Norway
Persson, Linda (författare)
Swedish Radiation Safety Authority, Stockholm, Sweden
Sipila, Petri (författare)
TUK-Radiation and Nuclear Safety Authority, Helsinki, Finland
visa färre...
 (creator_code:org_t)
Elsevier, 2014
2014
Engelska.
Ingår i: Brachytherapy. - : Elsevier. - 1538-4721 .- 1873-1449. ; 13:4, s. 420-423
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • PURPOSE:According to the American Association of Physicists in Medicine Task Group No. 43 (TG-43) formalism used for dose calculation in brachytherapy treatment planning systems, the absolute level of absorbed dose is determined through coupling with the measurable quantity air-kerma strength or the numerically equal reference air-kerma rate (RAKR). Traceability to established standards is important for accurate dosimetry in laying the ground for reliable comparisons of results and safety in adoption of new treatment protocols. The purpose of this work was to compare the source strength for a high-dose rate (HDR) (192)Ir source as measured using equipment traceable to different standard laboratories in Europe and the United States.METHODS AND MATERIALS:Source strength was determined for one HDR (192)Ir source using four independent systems, all with traceability to different primary or interim standards in the United States and Europe.RESULTS:The measured HDR (192)Ir source strengths varied by 0.8% and differed on average from the vendor value by 0.3%. Measurements with the well chambers were 0.5% ± 0.1% higher than the vendor-provided source strength. Measurements with the Farmer chamber were 0.7% lower than the average well chamber results and 0.2% lower than the vendor-provided source strength. All of these results were less than the reported source calibration uncertainties (k=2) of each measurement system.CONCLUSIONS:In view of the uncertainties in ion chamber calibration factors, the maximum difference in source strength found in this study is small and confirms the consistency between calibration standards in use for HDR (192)Ir brachytherapy.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine (hsv//eng)

Nyckelord

Ir-192 HDR; Source strength determination; Calibration; Traceability

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy